#United States #biopharmaceuticals #Newark, Delaware #NIIMBL #OAGi

Introduction

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) have recently introduced a transformative set of ontologies aimed at enhancing data interoperability and analytics across the biopharmaceutical manufacturing sector. This initiative, which signifies a crucial advancement in biomanufacturing, is the culmination of collaborative efforts within OAGi's Industrial Ontologies Foundry (IOF), bringing together experts, standards developers, and key stakeholders in the field.

The Role of Ontologies in Biopharmaceutical Manufacturing

Ontologies are structured frameworks that allow disparate systems to communicate more effectively by providing a shared vocabulary and common reference points. The newly devised ontologies encompass fundamental biomanufacturing concepts, which include process parameters, equipment specifications, quality attributes, various recipe types along with their components, processing steps, and material classifications. These elements are pivotal for establishing a consistent approach to data exchange and integration within the biopharmaceutical value chain.

Roger Hart, a Senior Fellow at NIIMBL, emphasizes the significance of this development, stating that ontologies create a